Navigation Links
Kent State University Stark Campus to Confer First Class of Nursing Students
Date:4/14/2008

nt wrong," she says. "They make us feel like they have a vested interest in us."

Keeping a close watch on the students' progress provides that special connection between the faculty and their class members, according to Cartechine. "The students really like the small class sizes and they appreciate having the same instructor for class and clinicals. It gives them a secure continuity of guidance and support," she says.

Both Wandel and Tortora already have confirmed positions in local hospitals upon graduation. With healthcare taking the lead as the fastest-growing industry in Ohio, the nursing program at Kent State Stark is very selective, taking only 40 students per year. In fall 2007, the Stark Campus hired four additional nursing faculty to accommodate the demand for nurses in the area.

"These nursing graduates are evidence of the campus' commitment to this program. This wouldn't have happened without the support of the deans," says Cartechine, in reference to Kent State Stark Dean Betsy V. Boze and Associate Dean Ruth Capasso. "Having this four-year program attracts qualified, strong students. It's an unbelievable experience to watch them mature to graduation."


'/>"/>
SOURCE Kent State University Stark Campus
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Exercise may lead to faster prostate tumor growth
2. UMDF Statement on the Connection Between Mitochondrial Disease and Autism
3. April 15 is Deadline for Input on State Aging Plan
4. 3T MRI plays significant role in detecting prostate cancer, study says
5. National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally
6. Iowa State University researcher looks to use nanoparticles for food safety
7. Open Letter to Presidential Candidates on State Health Care Reform
8. Massachusetts Affiliate of Susan G. Komen for the Cure(R) to Challenge States Leaders to Strengthen Breast Cancer Services
9. CamelBak(R) CEO Statement on BPA and Plastic Re-Usable Water Bottles
10. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
11. Paro, the Baby Seal Service Robot From Japan, Finds a New Home in the United States With Help From JETRO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...LUMBIA, S.C., Nov. 21 U...ttee for Quality Assurance (NCQA) ranked BlueChoic... of America,s Best Health Plans(TM), published in ... , The respected annual ranking ranks the na..., member satisfaction and NCQA accreditation score...
(Date:11/21/2008)...periments in mice find running increases productio...21 (HealthDay News) -- In experiments in mice, exe...tion of brain stem cells usually seen with aging, ... restoration of the brain,s ability to stave off a...store a neurochemical that is essential for the pr...
(Date:11/21/2008)...RSAW, Ind., Nov. 21 Symm...ndent provider of products to the global orthopedi...nced today that Brian S. Moore, President and Chie... President and Chief Financial Officer, are schedu...alth Care Conference at The New York Palace Hotel ...
(Date:11/21/2008)...NNEAPOLIS, Nov. 21 Three Minnesota... prizes during a special on-ice presentation at,t...Energy Center. The winners,were participants in T...from,ClearWay Minnesota(SM) and QUITPLAN(R) Servi...$5,000 in cash, while two runners-up,will get $1,...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Exercise Keeps the Brain Young 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2
... reported a study which states that fat men are ab.../This research was conducted by a team of research...this study, when obese men were hospitalized with ...ate better than thin men. This is said to be due t...
...al giant Novartis bagged the contract to make a ch...flu vaccines. The $54.8 million contract// was fin... than $300 million in federal contracts to fight a... in humans. Two other firms were also awarded con...
...searchers have developed a powerful method for cha...es called nucleosomes throughout the human genome/...clues for understanding and diagnosing cancer and ...may shed light on the role of nucleosomes in the p...
...y Commission said on Wednesday that about 375,000 ... Teether Beads are being recalled// because they p...at holds the teether beads in place can crack or b...e distributor, Kids II Inc. of Alpharetta, Ga., ha...
Other Medicine News:Health News:Scientists Map Key Landmarks in Human Genome 2Health News:Scientists Map Key Landmarks in Human Genome 3
(Date:11/20/2008)... PRELIMINARY TOP LINE RESULTS OF FIRST PHASE III ... FATIGUE, AND IMPROVEMENT IN DAILY FUNCTION, IN, ... , PALO ALTO, Calif., and BRUSSELS, Belgium, No...als, Inc. (Nasdaq: JAZZ ) and UCB (Euronext Brus...op-line results from the first of two,Phase III p...
(Date:11/20/2008)...VERSIDE, Calif., Nov. 20 Milk. It ...er than originally thought. After years of,resear...d peptides found in,cow,s milk that stimulate the... To view the Multimedia News Release, go to:, ht..., , While developing new cancer therapies, ...
(Date:11/20/2008)... JOLLA, Calif., Nov. 20 ...KA), announced today that it has submitted its,pi...eview under a Special,Protocol Assessment (SPA) p...n,(FDA). , Subject to securing an agreemen...e, prospective, double-blind, placebo-controlled a...
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 1Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 2Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 3Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 4Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 5Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 6Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 7Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 8Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 9Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 10Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 11Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 12Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 13Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 14Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 15Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 16Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 17Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 18Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 19Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 20Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 21Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 22Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 23Rural Metro Announces Results for Fiscal 2008 First Quarter 3B Fiscal 2007 Fourth Quarter and Full Year 6290 24Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 1Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 2Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 3Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 4Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 5Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 6Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 7Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics Inc s Drug Pipeline 6287 8Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 1Brokers Name Delta Dental the Best in Coverage Plan Design and Networks 6284 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3
...USINESS WIRE)--Jun 7, 2007 - Clinical results from...the American,Headache Society (AHS) annual meeting...itonin gene-related peptide (CGRP),receptor antago...two hours after dosing compared to placebo, and th...as generally well tolerated in,the study. Response...
...hieves All Key Endpoints for Both Efficacy and Saf...irstCall/ --,Indevus Pharmaceuticals, Inc. today a...kinetic trial for NEBIDO (testosterone,undecanoate...under,development for the treatment of male hypogo...ing Pharma AG, Germany. The data,from the recently...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
Portable - Battery Powered (6 size AA required). Fast, Lightweight Strain Gage Mechanism. Unit conversion (g, ct, oz, ozt, GN, dwt, mom, dwt, tael), Specific Gravity calculation, Piece Counting and P
...speed, stability and durability. Back-lighted Disp...es, multiple units of measure, piece counting and .../ISO output including date and time data from buil...ights only (selectable range). Shimadzu WindowsDir...
...tal stability control, analog display modes, multi...easure functions, auto print, and GLP/GMP/ISO outp...k. Touch-key calibration with external weights (s...face, WindowsDirect Capable. 120/240V A/C adapter,...
The EK-H Series offer 10 selectable units of measure
Medicine Products: